Cleveland Clinic

A new Cleveland Clinic study has programmed EHRs to limit the rate of chest X-rays among patients. How has it helped both their stay and treatment progression rates?

A new cohort from the Cleveland Clinic shows that the index could allow ICU clinicians to know whether a patient needs prone positioning or ECMO.

In 2018, investigators confirmed that one of the staple symptoms of multiple sclerosis—white matter demyelination—isn't always consistent.

The septic shock therapy was approved by the FDA last December. How has it fared in its first year of real-world clinical use?

Pauline Funchain, MD, highlights how humility may be one of the best characteristics in medicine right now.

Daniel Ontaneda, MD, provides insight into the implications of discovering a new subtype of multiple sclerosis: myelocortical MS.

Bruce Trapp, PhD, discusses his team’s recent discovery of a new subtype of multiple sclerosis: myelocortical MS.

One Cleveland Clinic practitioner describes his real-world experience with the use of mepolizumab in patients with severe eosinophilic asthma.

A team of investigators at Cleveland Clinic discover a novel subtype of multiple sclerosis which features neuronal loss but no demyelination of the brain’s white matter.

Cleveland Clinic investigators have discovered a novel form of the neurological condition which does not demyelinate the brain's white matter.

The Cleveland Clinic’s pioneer of minority programs plans to end health disparity.

Steve Case is on a mission to save healthcare, and he intends to do it by harnessing the consumer-empowering capabilities of the Internet.

On October 18-20, 2004, hundreds of top-level executives from the medical device, biotech, and pharmaceutical industries, entrepreneurs and investors from all across the globe, and thought leaders...